PDCD1LG2 and neoplasm: In the early setting, immune cell subpopulations (CD8 T cells, cytotoxic cells, macrophages), soluble mediators (IFN-γ, inflammatory chemokines), other immune checkpoint expression levels (PD-L2, IDO1, TIGIT), and tumor inflammation signature correlated with pCR in the GIADA trial [33].